Publications

PUBLICATIONS

Nanoscience

116. J Zhu, R Wei, G Hu*, H Wang, W Wang, H Wang, J Huang, Y Wang, Y Li*, H Meng*, Development of Injectable Thermosensitive Nanocomposite Hydrogel for Ratiometric Drug Delivery to Treat Drug Resistant Chondrosarcoma In Vivo. Small, 2024: 2310340.

115. H Wang, Y Chen, R Wei*, J Zhang, J Zhu, W Wang, Z Wang, Z Wupur, Y Li*, H Meng*, Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel‐Mediated Reprogramming of Cancer‐Associated Fibroblasts in Osteosarcoma, Advanced Materials, 2024,36(15): 2309591.

114. W Xu, Y Xiao, M Zhao, J Zhu, W Wang, P Wang*, H Meng*, Effective Treatment of Knee Osteoarthritis Using a Nano‐Enabled Drug Acupuncture Technology in Mice, Advanced Science, 2023, 10(28): 2302586.

113. X Liu, X Zhang, J Li, H Meng*, Enrichment of nano delivery platforms for mRNA-based nanotherapeutics. Medical Review, 2023, 3(4): 356-361.

112. M.R Hicks, X Liu, C.S Young, K Saleh Y Ji, J Jiang, M.R Emznmi, E Mokhonova, M.J Spencer*,H Meng*, A.D Pyle, Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD. Journal of Nanobiotechnology, 2023, 21(1): 303.

111. J Li, X Liu, K Ma, Y Liu, H Meng*, Understanding of surface chemistry of silica-based nanomaterials contributes to the design of safe and efficacious nanomedicine, Matter, 2023, 6(8): 2564-2567.

110. J Li, Y Xiao, Y Zhang, S Li, M Zhao, T Xia*, H Meng*, Pulmonary Delivery of Specialized Pro-Resolving Mediators-Based Nanotherapeutics Attenuates Pulmonary Fibrosis in Preclinical Animal Models, ACS Nano, 2023, 17(16): 15354-15370.

109. W Xu, Y Xiao, M Zhao, J Zhu, Y Wang, W Wang, P Wang*, H Meng*, Effective Treatment of Knee Osteoarthritis Using a Nano-Enabled Drug Acupuncture Technology in Mice. Advanced Science, 2023, 10(28): 2302586.

108. J Li, Q Xiang, T Xia, H Meng*, X Liu*, Design of nanoformulation of specialized pro-resolving mediators to facilitate inflammation resolution and disease treatment, Nano Today, 2023, 52: 101978.

107. S Dong, Z Feng, R Ma, T Zhang, J Jiang, Y Li, Y Zhang, S Li, X Liu, X Liu*, H Meng*, Engineered Design of a Mesoporous Silica Nanoparticle-Based Nanocarrier for Efficient mRNA Delivery in Vivo, Nano Letters, 2023, 23(6): 2137-2147.

106. Y Su*, X Zhou, H Meng, T Xia, H Liu, P Rolshausen,C Roper, J E.McLean, Y Zhang, A A.Keller, D Jassby, Cost–benefit analysis of nanofertilizers and nanopesticides emphasizes the need to improve the efficiency of nanoformulations for widescale adoption, Nature Food, 2022,1-11.

105. J Li, G Diamante, I S Ahn, D Wijaya, X Wang, C H Chang, S Ha, K Immadisetty, H Meng, A Nel*, X Yang*, T Xia*, Determination of the nanoparticle- and cell-specific toxicological mechanisms in 3D liver spheroids using scRNAseq analysis,Nano Today, 2022(47), 101652.

104. J Xu, T Chu, T Yu, N Li, C Wang, C Li, Y Zhang*, H Meng*, G Nie*, Design of Diselenide-Bridged Hyaluronic Acid Nano-antioxidant for Efficient ROS Scavenging to Relieve Colitis, ACS Nano, 2022, 16, 8, 13037-13048.

103. X Xie, J Jiang, X Liu, Y Cao, J Li, T Xia, H Meng*, Interleukin-10 plasmid delivery by polymeric nanocarrier shows efficient and safe tissue repair in acute muscle damage models in mice, Nano Today, 2022,46, 101544.

102. B Li, X Zhang, Z Wu, T Chu, Z Yang, S Xu, S Wu, Y Qie, Z Lu, F Qi, M Hu, G Zhao, J Wei, Y Zhao, G Nie, H Meng*, R Liu*, S Li*, Reducing postoperative recurrence of early-stage hepatocellular carcinoma by a wound-targeted nanodrug, Advanced Science, 2022, 2200477.

101. W Wang, H Sun, Y Gong, X Liu, X Liu, M Wang, S Liu, J Li, L Zhu*, H Meng*; Ratiometric co-delivery of hydroxychloroquine and calculated low-dose paclitaxel efficiently suppresses tumor growth in hepatocellular carcinoma mouse models in vivo, Nano Today, 2022, 101446.

100. J Li, X Gao, Y Wang, T Xia, Y Zhao, H Meng*; Precision design of engineered nanomaterials to guide immune systems for disease treatment, Matter, 2022, 5(4), 1162-1191.

99. X Liu, X Xie , J Jiang, M Lin, E Zheng, W Qiu, I Yeung, M Zhu, Q Li, T Xia, H Meng*, Use of nanoformulation to target macrophages for disease treatment, Advanced Functional Materials, 2021, 31, 2104487.

98.L You, Z Feng, Y Zhao, H Meng*, M Zhu*, The role of autophagy at the nano/bio interface - underlying mechanisms and therapeutic potential in cancer, Precision Nanomedicine, 2021.

97. Z Feng, H Meng*, Efficient nano-enabled therapy for gastrointestinal cancer using silicasome delivery technology, Science China Chemistry, 2021, 64, 1946–1957.

96. L Wang, Z Liu, Q Zhou, S Gu, X Liu, J Huang, H Jiang, H Wang, L Cao, J Sun, Y Shen, H Meng*, X Liu*, Prodrug nanoparticles rationally integrating stroma modification and chemotherapy to treat metastatic pancreatic cancer, Biomaterials, 2021, 278.

95. X Liu*, H Meng*, Consideration for the scale-up manufacture of nanotherapeutics—A critical step for technology transfer, View, 2021, 2, 20200190.

94. X Liu, J Jiang, Liao, Y-P, I Tang, E Zheng, W Qiu, M Lin, X Wang, Y Ji, Mei, K.-C, Q Liu, C.H Chang , Wainberg, Z. A, Nel, A. E*, H Meng*, Combination chemo-immunotherapy for pancreatic cancer using the immunogenic effects of an irinotecan silicasome nanocarrier plus Anti-PD-1, Advanced Science, 2021, 8, 2002147.

93. X Liu, J Jiang, C Chang, Y Liao, Lodico J J, I Tang, E Zheng, W Qiu, M Lin, X Wang, Y Ji, Mei, Nel A. E*, H Meng*, Development of facile and versatile platinum drug delivering silicasome nanocarriers for efficient pancreatic cancer chemo-immunotherapy, Small, 2021, 17, 2005993.

92. X Liu, H Sun, X Wang*, H Meng *, Immunological effects of nano-enabled hyperthermia for solid tumors: opportunity and challenge, Frontiers of Chemical Science and Engineering, 2021.

91. S Allen, X Liu, J Jiang, Y Liao, C Chang, A Nel*, H Meng*, Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor, Biomaterials, 2020, 269, 120635.

90. J Wang, Z Wang, G Chen, Y Wang, T Ci, H Li, X Liu, D Zhou, A R. K, Z Zhou, H Meng, J B. Buse, and Zhen Gu*. Injectable biodegradable polymeric complex for glucose-responsive insulin delivery, ACS nano, 2021, 15(3), 4294-4304.

89. J Li, X Wang, K-C Mei, C Chang, J Jiang, X Liu, Q Liu, L M.Guiney, M C.Hersam, Y-P Liao, H Meng T Xia*, Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes, Nano Today, 2021, 37, 101061.

88. H Li, Z Wang, Z Chen, T Ci, G Chen, D Wen, R Li, J Wang, H Meng, R.B Bell, Z Gu, G Dotti*, Z Gu*, Disrupting tumour vasculature and recruitment of aPDL1-loaded platelets control tumour metastasis, Nature Communications,2021, 12, 2773.

87. J Li, L M. Julia R. Downing, X Wang, C Chang, J Jiang, Q Liu, X Liu, Mei, K.-C,Y-P Liao, T Ma, H Meng, Mark C. H, A E. Nel*, T Xia*, Dissolution of 2D Molybdenum Disulfide Generates Differential Toxicity among Liver Cell Types Compared to Non‐Toxic 2D Boron Nitride Effects, Small, 2021, 2101084.

86. S Zhu, H Meng, Z Gu*, Y Zhao*,Research trend of nanoscience and nanotechnology – A bibliometric analysis of Nano Today, Nano Today, Volume 39, 2021, 101233.

85. Li J, Wang X, Chang C. H., Jiang J, Liu Q, Liu X, Liao Y.-P., Ma T, Meng H, Xia T*, Nanocellulose Length Determines the Differential Cytotoxic Effects and Inflammatory Responses in Macrophages and Hepatocytes, Small, 2021, 17, 2102545.

84. Y Ji, X Liu, J Li, X Xie, M Huang, J Jiang, YP Liao, T Donahue, H Meng*, Use of Ratiometrically Designed Nanocarrier Targeting CDK4/6 And Autophagy Pathways For Effective Pancreatic Cancer Treatment, Nature Communications, 2020, 11, 4249.

83. Y Wang, H Shi*, H Meng*, J Xu*, Targeting the PD-1/PD-L1 Cancer immune evasion axis: challenges and emerging strategies, Frontiers in Pharmacology, 2020, 11, 1578.

82. KC Mei, Y-P Liao, J Jiang, M Chiang, M Khazaieli, X Liu, X Wang, Q Liu, CH Chang, X Zhang, J Li, Y Ji, B Melano, D Telesca, T Xia, H Meng*, AE Nel*, Liposomal delivery of mitoxantrone and a cholesteryl indoximod prodrug provides effective chemo-immunotherapy in multiple solid tumors, ACS Nano, 2020, 14, 13343–13366.

81. X Liu, I Tang, Z A, Wainberg, H Meng*, Safety considerations of cancer nanomedicine – a key step towards translation, Small, 2020, 2000673.

80. X Liu, J Jiang, H Meng*, Transcytosis – An effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery, Theranostics, 2019, 9: 8018–8025.

79. H Nie, X Xie, D Zhang, Y Zhou, B Li, F Li, F Li, Y Cheng, H Mei, H Meng* , Lee Jia*, Use of lung-specific exosomes for miRNA-126 delivery in non-small cell lung cancer, Nanoscale, 2020, 877-887.

78. M R. Emami, C S. Young, Y Ji, X Liu, AD. Pyle*, H Meng*, and M J. Spencer*, Polyrotaxane nanocarriers can deliver CRISPR/Cas9 plasmid to dystrophic muscle cells to successfully edit the DMD gene, Advanced Therapeutics, 2019, 2, 1900061.

77. Y Ji, X Liu, M Huang, J Jiang, YP Liao, Q Liu, CH Chang, H Liao, J Lu, X Wang, SM Spencer, H Meng*, Development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo, Biomaterials, 2019, 192:416-428.

76. X Liu, J Jiang, R Chan, Y Ji, J Lu, YP Liao, M Okene, J Lin, P Lin, CH Chang, X Wang, I Tang, E Zheng, W Qiu, ZA. Wainberg, AE. Nel,* and H Meng*, Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer, ACS Nano, 2019, 13, 38-53.

75. H Meng*, A Nel*, Use of nano engineered approaches to overcome the stromal barrier in pancreas cancer, Advanced Drug Delivery Reviews, 2018, 130, 50-57.

74. X Liu, P Lin, I Perrett, J Lin, Y Liao, CH Chang, J Jiang, N Wu, T Donahue, Z Wainberg, A Nel*, H Meng*, Tumor-Penetrating Peptide Enhances Transcytosis of Silicasome-based Chemotherapy for Pancreatic Cancer, The Journal of Clinical Investigation, 2017, 127, 2007–2018 (highlighted by JCI editorial office).

73. H Meng*, W Leong, K W. Leong, C Chen, YL Zhao*, Walking the line: The fate of nanomaterials at biological barriers, Biomaterials, 2018, 174, 41–53.

72. J Lu, X Liu, Y-P Liao, F Salazar, B Sun W Jiang, C Chang, J Jiang, X Wang, A Wu, H Meng*,A Nel*, Nano-enabled pancreas cancer immunotherapy using immunogenic cell death and reversing immunosuppression. Nature Communications,2017, 8, 1811.

71. X Liu, J Jiang, Y Ji, J Lu, R Chan, H Meng*, Targeted drug delivery using iRGD peptide for solid cancer treatment, Molecular Systems Design and Engineering, 2017, 2, 370-379.

70. X Liu, J Jiang, A Nel*, H Meng*, Major effect of transcytosis on nano drug delivery to pancreatic cancer, Molecular & Cellular Oncology, 2017, e1335273.

69. X Liu, A Situ, Y Kang, K Villabroza, Y Liao, C H Chang, T Donahue, A E Nel*, H Meng*, Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Show Improved Efficacy and Safety over Liposomes for Pancreatic Cancer, ACS Nano, 2016, 10, 2702–2715.

68. Y Mao, K-S Shin, X Wang, Z Ji, H Meng*, CC Chui*, Semiconductor Electronic Label-Free Assay for Predictive Toxicology, Scientific Report, 2016, 24982.

67. H Meng, J I Zink, T Donahue, C Radu, Z Wainberg, and A Nel, Overcoming Specific Biological Barriers: Penetrating Stroma, Cancer Nanotechnology Plan, 2015, 29-35, National Cancer Institute, NIH.

66. Wang S, Riedinger A, Li H, Fu C, Liu H*, Li L, Liu T, Tan L, Barthel MJ, Pugliese G, De Donato F, Scotto D'Abbusco M, Meng X, Manna L, H Meng*, Pellegrino T*, Plasmonic Copper Sulfide Nanocrystals Exhibiting Near-infrared Photothermal and Photodynamic Therapeutic Effects, ACS Nano, 2015, 9, 1788–1800.

65. H Meng*, Wang M, Liu H, Liu X, Situ A, Wu B, Ji Z, Chang CH, Nel AE*, Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice. ACS Nano. 2015, 9, 3540-3557 (ACS editor choice paper).

64. H Meng*, R Wei, Use of Smart Designed Nanoparticles to Impact Cancer Surgery, Science Bulletin, 2015, 60, 142–143.

63. H Meng*, Y Zhao, J Dong, M Xue, YS Lin, Z Ji, W X. Mai, H Zhang, C H Chang, C. J Brinker, J I. Zink, and A E. Nel*, Two-Wave Nanotherapy To Target the Stroma and Optimize Gemcitabine Delivery To a Human Pancreatic Cancer Model in Mice, ACS Nano, 2013, 7, 10048–10065 (Highlighted by Nature Material).

62. H Meng*, WX Mai, H Zhang, M Xue, T Xia, S Lin, X Wang, Y Zhao, Z Ji, JI Zink, and AE Nel. Codelivery of an Optimal Drug/siRNA Combination Using Mesoporous Silica Nanoparticles To Overcome Drug Resistance in Breast Cancer in Vitro and in Vivo, ACS Nano, 2013, 7, 994-1005 (Highlighted by NCI Alliance for Nanotechnology in Cancer).

61. W X. Mai, H Meng*, Mesoporous Silica Nanoparticles: A Multifunctional Nanotherapeutic System, Integrative Biology, 2013, 5, 19-28.

60. H Meng, M Xue, JI Zink, and AE Nel, Development of Pharmaceutically Adapted Mesoporous Silica Nanoparticles Platform, The Journal of Physical Chemistry Letters, 2012, 3, 358-359.

59. H Meng, Xing G, Blanco E, Song Y, Zhao L, Sun B, Li X, Wang PC, Korotcov A, Li W, XJ Liang, C Chen, H Yuan, F Zhao, Z Chen, T Sun, Z Chai, M Ferrari, and YL Zhao. Gadolinium Metallofullerenol Nanoparticles Inhibit Cancer Metastasis Through Matrix Metalloproteinase Inhibition: Imprisoning Instead of Poisoning Cancer Cells, Nanomedicine: Nanotechnology, Biology and Medicine, 2012, 8, 136-146 (Cover paper).

58. H Meng, M Xue, T Xia, Z Ji, DY Tarn, JI Zink, and AE Nel, Use of Size and a Co-polymer Design Feature to Improve the Biodistribution and the Enhanced Permeability and Retention Effect of Doxorubicin-loaded Mesoporous Silica Nanoparticles in a Murine Xenograft Tumor Model, ACS Nano, 2011, 5, 131-144.

57. H Meng, S Yang, Z Li, T Xia, J Chen, Z Ji, H Zhang, X Wang, S Lin, C Huang, ZH Zhou, JI Zink, and AE Nel, Aspect Ratio Determines the Quantity of Mesoporous Silica Nanoparticle Uptake by a Small GTPase-dependant Macropinocytosis Mechanism, ACS Nano, 2011, 5, 4434-4447.

56. H Meng, M Liong, T Xia, Z Li, JI Zink, and AE Nel, Engineered Design of Mesoporous Silica Nanoparticles to Deliver Doxorubicin and P-Glycoprotein siRNA to Overcome Drug Resistance in a Cancer Cell Line, ACS Nano, 2010, 4, 4539-4550.

55. H Meng, M Xue, T Xia, YL Zhao, F Tamanoi, JF Stoddart, JI Zink, and AE Nel, Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves, Journal of the American Chemical Society, 2010, 132, 12690-12697 (Highlighted by NCI Alliance for Nanotechnology in Cancer).

54. X Liang¹, H Meng¹(¹equal contribution), Y Wang, H He, J Meng, J Lu, PC Wang, YL Zhao, X Gao, B Sun, C Chen, G Xing, D Shen, MM Gottesman, Y Wu, JJ Yin, and L Jia, Metallofullerene Nanoparticles Circumvent Tumor Resistance To Cisplatin By Reactivating Endocytosis, Proceedings of the National Academy of Sciences of the United States of America, 2010, 107, 7449-7454 (Highlighted by The Journal of Urology, 2010).

53. H Meng, G Xing, B Sun, F Zhao, H Lei, W Li, Y Song, Z Chen, H Yuan, X Wang, J Long, C Chen, XJ Liang, N Zhang, Z Chai, and YL Zhao, Potent Angiogenesis Inhibition by the Particulate Form of Fullerene Derivatives, ACS Nano, 2010, 4 , 2773-2783.

52. H Meng, T Xia, S George, and AE Nel, A Predictive Toxicological Paradigm for the Safety Assessment of Nanomaterials, ACS Nano, 2009, 3, 1620-1627 (highlighted by ACS Nano, "The Big Picture", 2009, 3, 1603-1604).

51. H Meng, T Xia, S George, and AE. Nel, Response to "Assessing the Safety of Nanomaterials by the Genomic Approach could be an Alternative", ACS Nano, 2009, 3, 3830-3831.

49. H Meng, Z Chen, GM Xing, H Yuan, C Chen, F Zhao, C Zhang, and YL Zhao, Ultrahigh Reactivity Provokes Nanotoxicity: Explanation of Oral Toxicity of Nano-Copper Particles, Toxicology Letters, 2007, 175, 102-110.

50. H Meng, Z Chen, GM Xing, H Yuan, C Chen, F Zhao, C Zhang, and YL Zhao, Ultrahigh Reactivity and Grave Nanotoxicity of Copper Nanoparticles, Journal of Radioanalytical and Nuclear Chemistry, 2007, 272, 595-598.

51. H Meng, B Sun, T Ren, H Yuan, G Xing, S Wang, Z Chen, L Qu, C Zhang, and YL Zhao, Chain Fullerene C60=C=C60=C=C60: Possible Way to All-Carbon Polymers, Journal of Nanoscience and Nanotechnology, 2008, 8, 1-4.

52. Z Chen¹, H Meng¹(¹equal contribution), GM Xing, C Chen, YL Zhao, G Jia, T Wang, H Yuan, C Ye, F Zhao, Z Chai, C Zhu, X Fang, B Ma, and L Wan, Acute Toxicological Effects of Copper Nanoparticles in vivo, Toxicology Letters, 2006, 163,109-120.

53. J Wang, Z Wang, G Chen, Y Wang, T Ci, H Li, X Liu, D Zhou, A Kahkoska, Z Zhou, H Meng, J Buse, Z Gu. Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery. 2021, ACS Nano. 15. 10.1021/acsnano.0c07291.

45. J Li, X Wang, KC Mei, CH Chang, J Jiang, X Liu, Q Liu, L Guiney, M Hersam, Y Liao, H Meng, T Xia. Lateral size of graphene oxide determines differential cellular uptake and cell death pathways in Kupffer cells, LSECs, and hepatocytes, Nano Today, 2020, 37, 101061.

44. J Liu, J Campagna, V J, R Damoiseaux, E Mokhonova, D Becerra, H Meng, EM McNally, A D Pyle, I Kramerova, M J Spencer, A Small-Molecule Approach to Restore a Slow-Oxidative Phenotype and Defective CaMKIIβ Signaling in Limb Girdle Muscular Dystrophy, Cell Reports Medicine, 2020, 1 (7), 100122.

43. Q Liu, X Wang, X Liu, S Kumar, G Gochman, Y Ji, Y Liao, CH Chang, W Situ, J Lu, J Jiang, KC Mei, H Meng, T Xia, A E. Nel, Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model, ACS Nano, 2019, 134, 4778-4794.

42. K Ali, A Nel, H Bunje, C DeSantis, A Andrews, R Blaik, G Zhen, H Meng, A Ozcan, S Tolbert, T Xia, J Zink, P Weiss, Nanoscience and Nanotechnology at UCLA, ACS Nano, 2019, 13. 6127-6129.

41. X Liu, Y Feng, G Xu, Yang Chen, Y Luo, J Song, Y Bao, C Yu, Y Li, H Ye, B Ke, B Chen, J Hu, J Xu, H Meng, H Zhang, H Shi, MAPK-Targeted Drug Delivered by a pH-Sensitive MSNP Nanocarrier Synergizes with PD-1 Blockade in Melanoma without T-Cell Suppression, Advanced Functional Materials, 2019, 29, 1806916.

40. A Nel, E Ruoslahti, H Meng, New Insights into “Permeability” as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics, ACS Nano, 2017, 11, 9567-9569.

39. W Jiang, X Wang, OJ. Osborne, Y Du, CH Chang, YP Liao, B Sun, J Jiang, Z Ji, R Li, X Liu, J Lu, S Lin, H Meng, T Xia, and AE. Nel, Pro-Inflammatory and Pro-Fibrogenic Effects of Ionic and Particulate Arsenide and Indium-Containing Semiconductor Materials in the Murine Lung, ACS Nano 2017, 11, 1869–1883.

38. Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, Balogh LP, Ballerini L, Bestetti A, Brendel C, Bosi S, Carril M, Chan WC, Chen C, Chen X, Chen X, Cheng Z, Cui D, Du J, Dullin C, Escudero A, Feliu N, Gao M, George M, Gogotsi Y, Grünweller A, Gu Z, Halas NJ, Hampp N, Hartmann RK, Hersam MC, Hunziker P, Jian J, Jiang X, Jungebluth P, Kadhiresan P, Kataoka K, Khademhosseini A, Kopeček J, Kotov NA, Krug HF, Lee DS, Lehr CM, Leong KW, Liang XJ, Ling Lim M, Liz-Marzán LM, Ma X, Macchiarini P, H Meng, Möhwald H, Mulvaney P, Nel AE, Nie S, Nordlander P, Okano T, Oliveira J, Park TH, Penner RM, Prato M, Puntes V, Rotello VM, Samarakoon A, Schaak RE, Shen Y, Sjöqvist S, Skirtach AG, Soliman MG, Stevens MM, Sung HW, Tang BZ, Tietze R, Udugama BN, VanEpps JS, Weil T, Weiss PS, Willner I, Wu Y Yang L, Yue Z, Zhang Q, Zhang Q, Zhang XE, Zhao Y, Zhou X, Parak WJ, Diverse Applications of Nanomedicine, ACS Nano 2017, 11, 2313−2381.

37. B Sun, X Wang, YP Liao, Z Ji, CH Chang, S Pokhrel, J Ku, X Liu, M Wang, D R. Dunphy, R Li, H Meng, L Mädler, C. J Brinker, A E. Nel, and T Xia, Repetitive Dosing of Fumed Silica Leads to Profibrogenic Effects through Unique Structure–Activity Relationships and Biopersistence in the Lung, ACS Nano, 2016, 10, 8054–8066.

36. R Li, Z Ji, C H Chang, D R. Dunphy, X Cai, H Meng, H Zhang, B Sun, X Wang, J Dong, S Lin, M Wang, Y Liao, C. J Brinker, A Nel, and T Xia, Surface Interactions with Compartmentalized Cellular Phosphates Explain Rare Earth Oxide Nanoparticle Hazard and Provide Opportunities for Safer Design, ACS Nano, 2014, 8, 1771–1783.

35. Wang X, Duch MC, Mansukhani N, Ji Z, Liao YP, Wang M, Zhang H, Sun B, Chang CH, Li R, Lin S, H Meng, Xia T, Hersam MC, Nel AE, Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials. ACS Nano, 2015, 9, 3032-3043.

34. F Zhao, H Meng, L Yan, B Wang, Y Zhao, Nanosurface Chemistry and Dose Govern the Bioaccumulation and Toxicity of Carbon Nanotubes, Metal Nanomaterials, and Quantum Dots in vivo, Science Bulletin, 2015, 60, 3–20.

33. H Meng* and Olivia J. Osborne Linking, thinking & fixing: the story about the 2015 Chemistry Nobel Prize and the future of science, Science Bulletin, 2015, 60, 2071-2076.

32. S Lin, X Wang, Z Ji, CH Chang, Y Dong, H Meng, YP Liao, M Wang, TB Song, S Kohan, T Xia, JI Zink, S Lin, A Nel, Aspect Ratio Plays a Role in the Hazard Potential of CeO2 Nanoparticles in Mouse Lung and Zebrafish Gastrointestinal Tract, ACS Nano. 2014, 27, 8, 4450-64.

31. X Wang, Z Ji ,CH Chang,H Zhang, M Wang, Y Liao, S Lin, H Meng, R Li , B Sun, L Winkle , KE. Pinkerton, JI. Zink, T Xia, and AE. Nel, Use of Coated Silver Nanoparticles to Understand the Relationship of Particle Dissolution and Bioavailability to Cell and Lung Toxicological Potential, Small, 2014, 10, 385–398.

30. A Nel, T Xia, H Meng, X WANG, S Lin, Z JI, and H Zhang, Nanomaterial Toxicity Testing in the 21st Century: Use of a Predictive Toxicological Approach and High Throughput Screening, Accounts of Chemical Research, 2013, 2013, 46, 607-621.

29. M Zhu, G Nie, H Meng, T Xia, AE Nel, and YL Zhao, Physicochemical Properties Determine Nanomaterial Cellular Uptake, Transport, and Fate, Accounts of Chemical Research, 2013, 46, 622-631.

28. J Lu, S Xin, H Meng, M Veldman, D Schoenfeld, C Che, R Yan, H Zhong, S Li, S Lin, A Novel Anti-Tumor Inhibitor Identified by Virtual Screen with PLK1 Structure and Zebrafish Assay, Plos One, 2013, e53317.

27. R Li, X Wang, Z Ji, B Sun, H Zhang, Ch Chang, S Lin, H Meng, YP Liao, M Wang, Z Li, AA Hwang, TB Song, R Xu, Y Yang, JI Zink, AE Nel, and T Xia, The Surface Charge and Cellular Processing of Covalently Functionalized Multiwall Carbon Nanotubes Determine Pulmonary Toxicity, ACS Nano, 2013, 7, 2352-2368.

26. D.L. Clemens, B.-Y. Lee , M. Xue , C. R. Thomas, H Meng, D. Ferris, A. E. Nel, J. I. Zink, M. A. Horwitz, Targeted Intracellular Delivery of Antituberculosis Drugs to Mycobacterium tuberculosis-Infected Macrophages via Functionalized Mesoporous Silica Nanoparticles, Antimicrobial Agents and Chemotherapy, 2012, 56, 2535-2545.

25. H Zhang, Z Ji, T Xia, H Meng, C Low-Kam, R Liu, S Pokhrel, S Lin, X Wang, YP Liao, M Wang, L Li, R Rallo, R Damoiseaux, D Telesca, L Mädler, Y Cohen, JI Zink, and AE Nel, Use of Metal Oxide Nanoparticle Band Gap to Develop a Predictive Paradigm for Oxidative Stress and Acute Pulmonary Inflammation, ACS Nano, 2012, 22, 4349-4368.

24. S Kang, G Zhou, P Yang, Y Liu, B Sun, T Huynha, H Meng, L Zhao, G Xing, C Chen, YL Zhao, and R Zhou, Molecular Mechanism of Pancreatic Tumor Metastasis Inhibition by Gd@C₈₂(OH)₂₂ and Its Implication For De Novo Design of Nanomedicine, Proceedings of the National Academy of Sciences of the United States of America, 2012, 109, 15431-15436.

23. H Zhang, DR Dunphy, X Jiang, H Meng, B Sun, D Tarn, M Xue, X Wang, S Lin, Z Ji, R Li, FL Garcia, J Yang, ML Kirk, T Xia, JI Zink, AE Nel, and CJ Brinker, Processing Pathway Dependence of Amorphous Silica Nanoparticle Toxicity: Colloidal vs Pyrolytic, Journal of the American Chemical Society, 2012, 134, 15790-15804.

22. Z Ji, X Wang, H Zhang, S Lin, H Meng, S George, T Xia, AE Nel, and JI Zink, Designed Synthesis of CeO2 Nanorods and Nanowires for Studying Toxicological Effects of Long Aspect Ratio Materials, ACS Nano, 2012, 6, 5366-5380.

21. S George, S Lin, Z Ji, CR. Thomas, L Li, M Mecklenburg, H Meng, X Wang, H Zhang, T Xia, JN Hohman, S Lin, JI Zink, PS Weiss, and AE Nel, Surface Defects on Plate-Shaped Silver Nanoparticles Contribute to Its Hazard Potential in a Fish Gill Cell Line and Zebrafish Embryos, ACS Nano, 2012, 6, 3745-3759.

20. S Lin, Y Zhao, Z, Ji, J Ear, C H Chang, H Zhang, C Low-Kam, K Yamada, H Meng, X Wang, R Liu, S Pokhrel, L Mädler, R Damoiseaux, T Xia, HA Godwin, S Lin, and AE Nel, Zebrafish High Throughput Screening to Study the Impact of Dissolving Metal Oxide Nanoparticles on the Hatching Enzyme, ZHE1, Small, 2012, 9, 1176-1185.

19. X Wang, T Xia, M Duch, Z Ji, H Zhang, R Li,B Sun, S Lin, H Meng, YP Liao, M Wang, TB Song, Y Yang, MC Hersam, and AE Nel, Pluronic F108 Coating Decreases the Lung Fibrosis Potential of Multiwall Carbon Nanotubes by Reducing Lysosomal Injury, Nano Letters, 2012, 12, 3050-3061.

18. T Xia, Y Zhao, T Sager, S George, S Pokhrel, N Li, D Schoenfeld, H Meng, S Lin, X Wang, M Wang, Z Ji, JI Zink, L Mädler, V Castranova, S Lin, and AE Nel, Decreased Dissolution of ZnO by Iron Doping Yields Nanoparticles with Reduced Toxicity in the Rodent Lung and Zebrafish Embryos, ACS Nano, 2011, 5, 1223-1235 (Highlighted by Nano Today).

17. H Zhang, T Xia, H Meng, M Xue, S George, Z Ji, X Wang, R Liu, M Wang, B France, R Rallo , R Damoiseaux, Y Cohen, KA Bradley, JI Zink, and AE Nel, Differential Expression of Syndecan-1 Mediates Cationic Nanoparticle Toxicity in Undifferentiated versus Differentiated Normal Human Bronchial Epithelial Cells, ACS Nano, 2011, 5, 2756-2769.

Cancer Nano Plan 2015,
published by NCI/NIH, Bethesda, Maryland, USA, 2016

Overcoming Specific Biological Barriers: Penetrating Stroma,

H Meng, J I Zink, T Donahue, C Radu, Z Wainberg, and A Nel

Advanced Delivery and Therapeutic Applications of RNAi,
John Wiley & Sons, Inc., 2013

Development of Pharmaceutically Adapted Mesoporous Silica Nanoparticles for siRNA Delivery

WX Mai, T Xia, and H Meng*

Nanotoxicology,
American Scientific Publisher, USA, 2007

Chapter 1: “Toxicological Effects of Nanomaterials (ADME/Tox and Target Organs).” Pages 1-28

YL Zhao, H Meng, Z Chen, F Zhao, and ZF Chai.

Chapter 3: “Interactions of Nanoparticles with Cells and Their Cellular Nanotoxicology.” Pages 51-60

YL Zhao, Z Chen, H Meng, X Wang, and G Jia.

Chapter 14: “Methodology for Nanotoxicology.” Pages 249-264

YL Zhao, F Zhao, Z Chen, H Meng, and ZF Chai.

Chapter 15: “Dependence of Nanotoxicity on Nanoscale Characteristics and Strategies for Reducing and Eliminating Nanotoxicity.” Pages 265-280

YL Zhao, H Meng, Z Chen, F Zhao, and ZF Chai.